Evidence exists that SELP, which is produced by glioma cells, together with its ligand P-Selectin Glycoprotein Ligand-1 (PSGL-1), is able to reduce the phagocytic activity of TAMs and increase the release of the immunosuppressive cytokines TGF-β and IL-10 [9]. Here, SELPLG is linked to central nervous system cancer.